Bioventus taps former Stryker, Smith+Nephew executive as new CEO

The board of managers at Bioventus unanimously appointed Ken Reali to succeed Tony Bihl as CEO when he retires April 20.

Advertisement

Mr. Reali has more than 28 years of experience in the medical device industry, including executive roles at Stryker, Smith+Nephew and Baxano Surgical.

Since 2015, he has operated as president and CEO of medical device company Clinical Innovations.

Beginning his career at Biomet, Mr. Reali progressed to marketing director and vice president at Stryker, senior vice president and general manager at Smith+Nephew and president and CEO of spinal device company Baxano Surgical.

He is on the boards of Ossio Integrative Orthopedics, AdvaMed and AdvaMed Accel and also serves as chairman of the ethics and compliance committee for AdvaMed. 

More articles on devices:
NuVasive recalls Magec system for scoliosis, advises surgeons to perform clinical follow-ups
Zimmer Biomet asks European hospitals to remove orthopedic spacer molds
Resurgens Orthopaedics postpones elective surgeries, remains open for urgent care

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.